基于药品说明书的潜在药物相互作用筛查在ICU接受注射用药患者中的诊断性能:以Lexi-Interact为对照的日本回顾性诊断准确性研究
该单中心回顾性队列研究纳入某三级医院两个ICU的345例成人ICU入住病例,在预设的三个时间点(第2天、第5天、ICU出院前一天)评估注射用药物间有临床意义的潜在药物相互作用(pDDI),以Lexi-Interact为对照比较基于药品说明书的pDDI识别性能。主要结局为基于药品说明书筛查的阴性预测值,结果为0.98,灵敏度0.80、特异度0.91、阳性预测值0.51,两者一致性为中等(加权kappa=0.57),聚类bootstrap分析(10,000次重抽样)证实诊断性能估计稳定。仅由Lexi-Interact识别的相互作用以C类为主,仅1例D类,无X类。作者认为基于药品说明书的筛查可作为实用的初筛方法,但严重程度分类的差异提示互补使用国际数据库可能有助于提升临床解读与用药安全。
要点
- 在345例成人ICU入住病例中,基于药品说明书的注射用药物pDDI筛查与Lexi-Interact相比阴性预测值为0.98,灵敏度0.80、特异度0.91、阳性预测值0.51。
- 两种来源的一致性为中等(加权kappa=0.57),聚类bootstrap分析(10,000次重抽样)证实诊断性能估计稳定。
- 仅由Lexi-Interact识别的相互作用以C类为主,仅1例D类,无X类。
- 作者认为基于药品说明书的筛查可作为实用的初筛方法,但严重程度分类的差异提示互补使用国际数据库可能有助于提升临床解读与用药安全。
适用人群与场景
- 某三级医院两个ICU的成人ICU入住病例,年龄≥18岁,涉及接受注射用药的患者。
诊断标准与关键阈值
- 在预设的三个时间点(第2天、第5天、ICU出院前一天)评估注射用药物间有临床意义的pDDI。
- 以Lexi-Interact为对照比较基于药品说明书的pDDI识别。
研究设计与关键结果
- 研究类型为单中心回顾性队列研究,纳入345例符合标准的ICU入住病例,在三个预设时间点评估注射用药物间有临床意义的pDDI。
- 基于药品说明书的pDDI筛查与Lexi-Interact相比:阴性预测值0.98、灵敏度0.80、特异度0.91、阳性预测值0.51。
- 两种来源的一致性为中等(加权kappa=0.57)。
- 聚类bootstrap分析(10,000次重抽样)证实诊断性能估计稳定。
- 仅由Lexi-Interact识别的相互作用以C类为主,仅1例D类,无X类。
证据类型、等级与局限
- 证据类型:单中心回顾性诊断准确性研究,以Lexi-Interact为实用性对照。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,基于药品说明书的pDDI筛查可作为实用的初筛方法,与Lexi-Interact分类具有实质性一致性。
- 作者认为,严重程度分类的差异提示互补使用国际公认数据库可能有助于提升重症监护中的临床解读与用药安全。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: No established gold standard exists for identifying potential drug-drug interactions (pDDIs). In Japan, package inserts are commonly used for pDDI screening in clinical practice, whereas internationally curated databases such as Lexi-Interact serve widely as clinical decision support tools. However, the performance of package insert-based pDDI identification in intensive care unit (ICU) settings has not been fully evaluated. Therefore, in this study, we aimed to evaluate the concordance of package insert-based screening for detecting pDDIs in ICU patients receiving injectable medications, using Lexi-Interact as the comparator.
METHODS: This single-center retrospective cohort study included adult ICU admissions involving patients aged ≥ 18 years at two ICUs of a tertiary hospital. Clinically significant pDDIs among injectable drugs were assessed at three predefined timepoints (day 2, day 5, and the day before ICU discharge). Package insert-based pDDI identification was compared with Lexi-Interact as the comparator. The primary outcome was the negative predictive value (NPV) of package insert-based screening for clinically significant pDDIs. Diagnostic performance was evaluated using sensitivity, specificity, positive predictive value (PPV), and weighted kappa in relation to Lexi-Interact as a pragmatic comparator. Robustness was assessed via ICU admission-level cluster bootstrap analysis with 10,000 resamples.
RESULTS: Among 345 eligible ICU admissions, package insert-based screening yielded an NPV of 0.98, a sensitivity of 0.80, a specificity of 0.91, and a PPV of 0.51 compared with Lexi-Interact. Agreement between the two sources was moderate (weighted kappa = 0.57). Bootstrap analysis confirmed stable estimates of diagnostic performance. Interactions identified exclusively by Lexi-Interact were predominantly category C, with only one category D interaction and no category X interactions.
CONCLUSIONS: In ICU settings, package insert-based identification of pDDIs involving injectable drugs showed high NPV, sensitivity, and specificity relative to Lexi-Interact. These findings suggest that package insert-based screening may serve as a practical initial screening approach with substantial concordance with Lexi-Interact classifications in ICU pharmacotherapy. Nevertheless, discrepancies in interaction severity classification highlight the potential benefit of complementary use of internationally established databases to enhance clinical interpretation and medication safety in critical care.
参考来源
- Kato T, Yasukawa N, Uno E, et al. Diagnostic performance of package insert-based screening for potential drug-drug interactions in ICU patients receiving injectable medications: a retrospective diagnostic accuracy study using Lexi-Interact as the comparator in Japan. J Intensive Care. 2026. PMID: 42304184. doi:10.1186/s40560-026-00890-7
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。